Aquigenbio

In the ever-evolving pharmaceutical industry, the importance of API (Active Pharmaceutical Ingredient) impurities cannot be overstated. These impurities, which are present in small quantities within the API, can have a significant impact on the safety, efficacy, and quality of the final drug product. As a result, pharmaceutical companies must be diligent in their selection of

In the pharmaceutical industry, the development and manufacture of Active Pharmaceutical Ingredients (APIs) require meticulous attention to quality control and impurity management. One particularly challenging class of impurities to address is the N-nitrosamines, also known as N-nitroso compounds. These impurities have garnered significant attention in recent years due to their potential carcinogenic properties, leading to

The development of Active Pharmaceutical Ingredients (APIs) is a complex and meticulous process that requires stringent quality control measures to ensure the safety and efficacy of the final drug product. One critical aspect of this process is the identification and quantification of impurities, which can have significant implications for the overall quality and safety of

Pharmaceutical products require stringent purity standards to guarantee their safety and effectiveness. Despite these efforts, impurities can still arise during production. These impurities can originate from various sources, including starting materials, by-products, synthesis intermediates, and degradation products. Identifying and controlling these impurities is crucial for ensuring the quality and efficacy of the final product. With

Viloxazine is an antidepressant which was previously used for the treatment of depressive and anxiety disorders. In this blog, we will explore the role of Viloxazine in mental health treatment. Viloxazine is a selective norepinephrine reuptake inhibitor (SNRI) that was previously used as an antidepressant in Europe. It belongs to a class of medications known